Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Increase in ST-11 serogroup W Neisseria meningitidis invasive meningococcal disease in Canada, 2016-2018.

Tsang RS, Hoang L, Tyrrell GJ, Minion J, Van Caeseele P, Kus JV, Lefebvre B, Haldane D, Garceau R, German G, Zahariadis G, Hanley B.

Can Commun Dis Rep. 2019 Jun 6;45(6):164-169. doi: 10.14745/ccdr.v45i06a04. eCollection 2019 Jun 6.

2.

First Human Case of Metacestode Infection Caused by Versteria sp. in a Kidney Transplant Recipient.

Barkati S, Gottstein B, Mu Ller N, Sheitoyan-Pesant C, Metrakos P, Chen T, Garceau R, Libman MD, Ndao M, Yansouni CP.

Clin Infect Dis. 2019 Feb 1;68(4):680-683. doi: 10.1093/cid/ciy602.

PMID:
30212859
3.

Heterophilic interference in specimens yielding false-reactive results on the Abbott 4th generation ARCHITECT HIV Ag/Ab Combo assay.

Lavoie S, Caswell D, Gill MJ, Kadkhoda K, Charlton CL, Levett PN, Hatchette T, Garceau R, Maregmen J, Mazzulli T, Needle R, Kadivar K, Kim J.

J Clin Virol. 2018 Jul;104:23-28. doi: 10.1016/j.jcv.2018.03.014. Epub 2018 Apr 12.

PMID:
29704735
4.

Interim laboratory testing guidance for the detection of non-tuberculous Mycobacterium (NTM) infections in post-operative patients exposed to heater-cooler units.

Antonation K, Patel S, Waddell JT, Poliquin PG, Alexander DC, Hoang L, Farrell D, Garceau R, Haldane D, Jamieson F, Marchand R, MacKeen A, Marcino D, Theriault S, Tyrrell GJ, Zahariadis G, Zelyas N; Canadian Public Health Laboratory Network.

Can Commun Dis Rep. 2017 Jan 5;43(1):25-28. eCollection 2017 Jan 5.

5.

First Report of Clostridium lavalense Isolated in Human Blood Cultures.

Garceau R, Bourque C, Thibault L, Côté JC, Longtin J, Domingo MC.

Can J Infect Dis Med Microbiol. 2016;2016:7231805. doi: 10.1155/2016/7231805. Epub 2016 Jul 10.

6.

Decline in Decreased Cephalosporin Susceptibility and Increase in Azithromycin Resistance in Neisseria gonorrhoeae, Canada.

Martin I, Sawatzky P, Liu G, Allen V, Lefebvre B, Hoang L, Drews S, Horsman G, Wylie J, Haldane D, Garceau R, Ratnam S, Wong T, Archibald C, Mulvey MR.

Emerg Infect Dis. 2016 Jan;22(1):65-7. doi: 10.3201/eid2201.151247.

7.

Molecular Assay for Detection of Ciprofloxacin Resistance in Neisseria gonorrhoeae Isolates from Cultures and Clinical Nucleic Acid Amplification Test Specimens.

Peterson SW, Martin I, Demczuk W, Bharat A, Hoang L, Wylie J, Allen V, Lefebvre B, Tyrrell G, Horsman G, Haldane D, Garceau R, Wong T, Mulvey MR.

J Clin Microbiol. 2015 Nov;53(11):3606-8. doi: 10.1128/JCM.01632-15. Epub 2015 Aug 19.

8.

Cloacibacillus sp., a Potential Human Pathogen Associated with Bacteremia in Quebec and New Brunswick.

Domingo MC, Yansouni C, Gaudreau C, Lamothe F, Lévesque S, Tremblay C, Garceau R.

J Clin Microbiol. 2015 Oct;53(10):3380-3. doi: 10.1128/JCM.01137-15. Epub 2015 Jul 29.

9.

Molecular Assay for Detection of Genetic Markers Associated with Decreased Susceptibility to Cephalosporins in Neisseria gonorrhoeae.

Peterson SW, Martin I, Demczuk W, Bharat A, Hoang L, Wylie J, Allen V, Lefebvre B, Tyrrell G, Horsman G, Haldane D, Garceau R, Wong T, Mulvey MR.

J Clin Microbiol. 2015 Jul;53(7):2042-8. doi: 10.1128/JCM.00493-15. Epub 2015 Apr 15.

10.

Canadian Public Health Laboratory Network national syphilis laboratory testing recommendations: INTRODUCTION.

Members of the Canadian Public Health Laboratory Network Syphilis Laboratory Task Group during authorship (co-chairs and membership in alphabetical order), Tsang RS, Morshed M, Allen V, Chernesky MA, Fonseca K, Garceau R, Jayaraman GC, Kadkhoda K, Lee BE, Levett PN, Radons SM, Serhir B, Singh AE, Wong T.

Can J Infect Dis Med Microbiol. 2015 Jan-Feb;26 Suppl A:4A-5A. No abstract available.

11.

Canadian Public Health Laboratory Network laboratory guidelines for the diagnosis of neurosyphilis in Canada.

Wong T, Fonseca K, Chernesky MA, Garceau R, Levett PN, Serhir B.

Can J Infect Dis Med Microbiol. 2015 Jan-Feb;26 Suppl A:18A-22A.

12.

Detection of enterovirus D68 in Canadian laboratories.

Hatchette TF, Drews SJ, Grudeski E, Booth T, Martineau C, Dust K, Garceau R, Gubbay J, Karnauchow T, Krajden M, Levett PN, Mazzulli T, McDonald RR, McNabb A, Mubareka S, Needle R, Petrich A, Richardson S, Rutherford C, Smieja M, Tellier R, Tipples G, LeBlanc JJ.

J Clin Microbiol. 2015 May;53(5):1748-51. doi: 10.1128/JCM.03686-14. Epub 2015 Mar 4.

13.

Whole-genome phylogenomic heterogeneity of Neisseria gonorrhoeae isolates with decreased cephalosporin susceptibility collected in Canada between 1989 and 2013.

Demczuk W, Lynch T, Martin I, Van Domselaar G, Graham M, Bharat A, Allen V, Hoang L, Lefebvre B, Tyrrell G, Horsman G, Haldane D, Garceau R, Wylie J, Wong T, Mulvey MR.

J Clin Microbiol. 2015 Jan;53(1):191-200. doi: 10.1128/JCM.02589-14. Epub 2014 Nov 5.

14.

Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study.

Mannstadt M, Clarke BL, Vokes T, Brandi ML, Ranganath L, Fraser WD, Lakatos P, Bajnok L, Garceau R, Mosekilde L, Lagast H, Shoback D, Bilezikian JP.

Lancet Diabetes Endocrinol. 2013 Dec;1(4):275-83. doi: 10.1016/S2213-8587(13)70106-2. Epub 2013 Oct 7. Erratum in: Lancet Diabetes Endocrinol. 2014 Jan;2(1):e3. Dosage error in article text.

PMID:
24622413
15.

Antimicrobial susceptibilities and distribution of sequence types of Neisseria gonorrhoeae isolates in Canada: 2010.

Martin I, Sawatzky P, Liu G, Allen V, Lefebvre B, Hoang L, Lovgren M, Haldane D, Caeseele PV, Horsman G, Garceau R, Ratnam S, Wong T, Gilmour M.

Can J Microbiol. 2013 Oct;59(10):671-8. doi: 10.1139/cjm-2013-0357. Epub 2013 Aug 27.

PMID:
24102220
16.

Herpes simplex virus type 1 is the leading cause of genital herpes in New Brunswick.

Garceau R, Leblanc D, Thibault L, Girouard G, Mallet M.

Can J Infect Dis Med Microbiol. 2012 Spring;23(1):15-8.

17.

Adenovirus serotype 14 infection, New Brunswick, Canada, 2011.

Girouard G, Garceau R, Thibault L, Oussedik Y, Bastien N, Li Y.

Emerg Infect Dis. 2013 Jan;19(1):119-22. doi: 10.3201/eid1901.120423.

18.

Province-wide adenovirus type 3 outbreak with severe cases in New Brunswick.

Girouard G, Garceau R, Thibault L, Bourque C, Bastien N, Li Y.

Can J Infect Dis Med Microbiol. 2011 Spring;22(1):e4-6.

19.

Oseltamivir-resistant pandemic H1N1 influenza.

Webster D, Li Y, Bastien N, Garceau R, Hatchette TF.

CMAJ. 2011 Apr 19;183(7):E420-2. doi: 10.1503/cmaj.100313. Epub 2011 Feb 14. Review. No abstract available.

20.

Protective effect of single-dose adjuvanted pandemic influenza vaccine in children.

Van Buynder PG, Dhaliwal JK, Van Buynder JL, Couturier C, Minville-Leblanc M, Garceau R, Tremblay FW.

Influenza Other Respir Viruses. 2010 Jul;4(4):171-8. doi: 10.1111/j.1750-2659.2010.00146.x.

21.

Identification of performance problems in a commercial human immunodeficiency virus type 1 enzyme immunoassay by multiuser external quality control monitoring and real-time data analysis.

Kim J, Swantee C, Lee B, Gunning H, Chow A, Sidaway F, Sherlock C, Garceau R, Dimech W, Malloch L; CAHCLS Laboratories.

J Clin Microbiol. 2009 Oct;47(10):3114-20. doi: 10.1128/JCM.00892-09. Epub 2009 Jul 29.

22.

Macrolide resistance in streptococcal pharyngitis.

Lavergne V, Thibault L, Garceau R.

CMAJ. 2007 Jul 17;177(2):177. No abstract available.

23.

Self-reported medication errors among employees of a pharmaceutical company and their families.

Mikhelashvili T, Spann L, Garceau R, Gagnon JP.

J Am Pharm Assoc (2003). 2007 Mar-Apr;47(2):181-5. No abstract available.

PMID:
17510005
24.

Legionella jordanis lower respiratory tract infection: case report and review.

Vinh DC, Garceau R, Martinez G, Wiebe D, Burdz T, Reimer A, Bernard K.

J Clin Microbiol. 2007 Jul;45(7):2321-3. Epub 2007 May 9. Review.

27.

Improved gastrointestinal tolerance and patient preference of enteric-coated sulfasalazine versus uncoated sulfasalazine tablets in patients with rheumatoid arthritis.

Weaver A, Chatwell R, Churchill M, Kastanek L, Beyene J, Garceau R, Docsa S, Diani A.

J Clin Rheumatol. 1999 Aug;5(4):193-200.

PMID:
19078385
28.

[Effect of pretreatment counseling on discontinuation rates in women given depo-medroxyprogesterone acetate for contraception].

Lei Z, Wu S, Garceau RJ.

Zhonghua Fu Chan Ke Za Zhi. 1997 Jun;32(6):350-3. Chinese.

PMID:
9596915
29.

A dose-response study of alprostadil sterile powder (S.Po.) (Caverject) for the treatment of erectile dysfunction in Korean and Indonesian men.

Choi HK, Adimoelja A, Kim SC, Soebadi DM, Seong DH, Garceau RJ.

Int J Impot Res. 1997 Mar;9(1):47-51.

PMID:
9138059
30.

Effect of pretreatment counseling on discontinuation rates in Chinese women given depo-medroxyprogesterone acetate for contraception.

Lei ZW, Wu SC, Garceau RJ, Jiang S, Yang QZ, Wang WL, Vander Meulen TC.

Contraception. 1996 Jun;53(6):357-61.

PMID:
8773423
31.

The use of alprostadil sterile powder in a home self-injection study of Asian men with erectile dysfunction.

Wu CC, Xue ZY, Apichat K, Huang ST, He Z, Garceau RJ.

Clin Ther. 1996 Mar-Apr;18(2):256-64.

PMID:
8733986
32.

The value of prophylactic antibiotics after vaginal hysterectomy.

Boyd ME, Garceau R.

Am J Obstet Gynecol. 1976 Jul 1;125(5):581-5.

PMID:
937384

Supplemental Content

Loading ...
Support Center